PAVmed Inc. Logo

PAVmed Inc.

A diversified medical technology company developing devices, diagnostics, and digital health.

PAVM | US

Overview

Corporate Details

ISIN(s):
US70387R1068
LEI:
Country:
United States of America
Address:
360 MADISON AVENUE, 10017 NEW YORK

Description

PAVmed Inc. is a commercial-stage, diversified medical technology company that develops and commercializes products across the medical device, diagnostics, and digital health sectors. The company operates through a shared-services business model to support its majority-owned subsidiaries. Its key subsidiary, Lucid Diagnostics, offers the EsoGuard® Esophageal DNA Test, a diagnostic tool for the early detection of esophageal precancer. Another subsidiary, Veris Health, provides a digital health platform for remote patient monitoring to enhance personalized cancer care. PAVmed's strategy focuses on acquiring and developing early-stage medical technologies to address unmet clinical needs for patients and healthcare systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PAVmed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PAVmed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PAVmed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KAZIA THERAPEUTICS LTD Logo
Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.
United States of America
KZIA
Keros Therapeutics, Inc. Logo
Develops protein therapeutics for disorders linked to TGF-β signaling.
United States of America
KROS
Kura Oncology, Inc. Logo
Clinical-stage biopharma company developing precision medicines for cancer treatment.
United States of America
KURA
Larimar Therapeutics, Inc. Logo
A clinical-stage biotech developing treatments for complex rare diseases.
United States of America
LRMR
Lexaria Bioscience Corp. Logo
A biotech company with a patented platform to improve oral drug delivery and absorption.
United States of America
LEXX
LigaChem Biosciences Inc. Logo
Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.
South Korea
141080
Linical Co., Ltd. Logo
A global CRO providing a full spectrum of drug development services for biopharma.
Japan
2183
Lipigon Pharmaceuticals AB Logo
A clinical-stage company developing therapeutics for lipid-related disorders.
Sweden
LPGO
Lipum AB Logo
Clinical-stage biopharma developing novel treatments for chronic inflammatory diseases.
Sweden
LIPUM
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage pharma company developing PP2A inhibitors to enhance cancer therapies.
United States of America
LIXT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.